Feature | Breast Biopsy Systems | October 17, 2019 | By Harriet Borofsky, M.D.

Save the Biopsy Suite

A case study of tomosynthesis-guided prone breast biopsies at Mills-Peninsula Women’s Center

A patient prepares to have a tomosynthesis-guided prone breast biopsy using the Hologic Affirm prone biopsy system.

A patient prepares to have a tomosynthesis-guided prone breast biopsy using the Hologic Affirm prone biopsy system.

Harriet Borofsky, M.D.

Harriet Borofsky, M.D.

The current body of research supporting digital breast tomosynthesis (DBT or 3-D mammography) is now overwhelming, with numerous single and multi-institutional studies showing this technology improves screening outcomes and accuracy by increasing breast cancer detection rates, decreasing recall rates and increasing specificity. Since DBT debuted in 2011, its utilization has quickly increased.

A recent JAMA Internal Medicine1 research letter showed that use of DBT for breast cancer screening has grown rapidly, increasing from almost 13 percent of screening exams in 2015 to more than 43 percent in 2017. More than 93 percent of insured women now have coverage for DBT exams. The American Society of Breast Surgeons’ (ASBrS) newly released, updated breast cancer screening guidelines explicitly named DBT as the preferred modality for annual mammography. At this point in time, it is certainly reasonable to say that this technology is now considered the standard of care for both screening and diagnostic mammography.

However, despite the confirmed benefit and widespread acceptance of digital breast tomosynthesis, a gap exists between its utilization and its requirement for tomosynthesis-guided interventional procedures.

A New Challenge

While DBT has significantly improved mammography outcomes, it has also presented new challenges: detection of subtle, but definite areas of architectural distortion and amorphous calcifications seen only on tomosynthesis images without ultrasound correlates that they are not able to be confidently seen and biopsied using 2-D stereotactic biopsy systems. This has led to an increase in non-diagnostic procedures and the need for surgical excisional biopsies.

Thankfully, the introduction and availability of tomosynthesis-guided biopsy technologies has solved this critical problem — first utilizing add-on upright units and more recently with dedicated prone systems.   

The advantage of add-on upright units is the ability to perform tomosynthesis-guided biopsies quickly and efficiently, increasing room functionality. However, they also have the distinct disadvantages of limiting capacity for diagnostic and screening exams, which may lead to backlog and vasovagal reactions, which are common with upright positioning.   

A Case Study of Tomosynthesis-guided Prone Biopsy

New prone tomosynthesis-guided biopsy units now have all the advantages of 3-D localization — improved conspicuity of all lesions (including those only seen on tomosynthesis images), improved efficiency of procedures and lower radiation dose — with the added advantages of a dedicated procedure room to increase overall capacity and prone positioning to reduce concern of vasovagal reactions.

At Mills-Peninsula Women’s Center in California, we’ve found that our ability to perform tomosynthesis-guided prone biopsies has been integral to our reputation as a referral center for all breast procedures and a center of excellence for our patients. Thanks to this technology, we can perform challenging procedures quickly and efficiently.

Difficult Procedures

A recent patient referral to Mills-Peninsula illustrates this: A patient from an outside facility had a baseline screening mammogram detecting suspicious calcifications requiring biopsy, but with breast thickness of 18 mm, making a standard perpendicular approach with core needle biopsy impossible to perform. A surgical excisional biopsy was initially recommended. However, the surgeon referred the patient on to us at Mills-Peninsula, knowing we had the expertise and technology to perform this procedure for this patient.

What was impossible for another facility was now a straightforward and quick procedure thanks to the advancements of tomosynthesis-guided biopsy and the functionality of a lateral arm approach on the prone system.

Thanks to the lateral needle approach, access to parallel needle placement is available, quick and efficient. Essentially any lesion in the breast, even breast tissue that compresses very thin, is accessible for biopsy.

Patient Experience

Tomosynthesis-guided biopsies have had an enormous positive impact on patient experience. Procedures are now quickly and confidently performed because less imaging is needed, the field of view is larger and lesion conspicuity is increased. That means decreased procedure time for the patient with the breast in compression.

Previously, stereotactic biopsies could take 30-45 minutes to complete. This was a frustrating reality of older systems and technologies. However, thanks to newer biopsy technology, procedures can be completed in about 10 minutes.

In achieving this speed, one of the most important considerations is conspicuity of lesions. Whether it is calcifications, architectural distortion, round or irregular masses — if you can target on the first sweep of tomosynthesis images and see the lesion, then you can save a lot of time.

Another consideration is patient comfort. For many, prone systems offer a more compassionate, comfortable experience compared to their upright counterpart. That’s because direct view of the biopsy needle is eliminated with prone systems, helping to reduce worry of vasovagal reaction or other adverse responses.

Improved Workflow

Having a dedicated biopsy suite with a prone biopsy system improves workflow and capacity — something that is especially important at Mills-Peninsula due to our high volume and our patient commitment to have biopsy procedures performed within three days.

Upright biopsy systems decrease capacity for screening and diagnostic mammography, which may impact scheduling, leading to backlogs. For every biopsy conducted on an upright system, a facility loses scheduling for approximately four mammography procedures. This can have an especially negative impact, resulting in patient dissatisfaction, patient out-migration and lost revenue.

Having a prone system in a dedicated biopsy suite eliminates these concerns, allowing for more flexible scheduling, increased capacity for procedures and more efficient workflow.

Increased Capacity

Another benefit of the prone biopsy unit has been increased capacity for these needed procedures.
At Mills-Peninsula, we used to schedule a maximum of three stereos per day. Now we can perform three procedures in the morning and two in the afternoon. It is a real game changer for our facility.

Save the Biopsy Suite

Our experience with tomosynthesis-guided prone biopsy at Mills-Peninsula has solidified our commitment to this technology. While some may perceive benefits in transitioning to upright-only environments, we have experienced the benefits of tomosynthesis-guided prone biopsies at our breast center.

Truly, there is a case to be made to save the biopsy suite, and we have made it.


Harriet Borofsky, M.D., is the medical director of breast imaging with Mills-Peninsula Medical Center in San Meteo, Calif. She is a graduate of Harvard Medical School and completed her residency and fellowship at Stanford University Hospital, Calif.



Adoption of Digital Breast Tomosynthesis in Clinical Practice, I. Richman et al, JAMA Intern Med., doi:10.1001/jamainternmed.2019.1058. Published online June 24, 2019. https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2.... Accessed Aug. 27, 2019.

Related content:

Improving Clinical Image Quality for Breast Imaging

Roundtable: Stereotactic Breast Imaging

Related Content

A recent study earlier this year in the journal Nature, which included researchers from Google Health London, demonstrated that artificial intelligence (AI) technology outperformed radiologists in diagnosing breast cancer on mammograms
Feature | Breast Imaging | April 06, 2020 | By Samir Parikh
A recent study earlier this year in the journal Nature,
Feature | Breast Density | April 03, 2020 | By Dayna Williams M.D., Shivani Chaudhry, M.D., and Laurie R. Margolies, M.D.
Breast cancer is the most common cance
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2
News | Mammography | March 25, 2020
March 25, 2020 — The...
The 2020 Society of Breast Imaging/American College of Radiology (SBI/ACR) annual symposium has been cancelled, and the event rescheduled for April 8-11, 2020, in Savannah, Ga. #COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SBI20
News | Society of Breast Imaging (SBI) | March 16, 2020
March 16, 2020 — The 2020 Society of Breast Imaging/American College of Radiology (...
DBT, sometimes called 3-D mammography, emerged in the last decade as a powerful tool for breast cancer screening

Images in a 57-year-old woman noted to have "good prognosis" invasive cancer detected at digital breast tomosynthesis (DBT) screening. (a) Craniocaudal view of the left breast obtained with the two-dimensional digital mammography (DM) portion of the DM/DBT screening study demonstrates a subtle area of distortion in the medial left breast. (b) Single-slice image from the left craniocaudal DBT portion of the screening study shows an area of bridging distortion (circle). (c) Electronically enlarged image of the area of concern seen on the left craniocaudal view in a single DBT slice as shown in b. (d) Targeted US scan demonstrates two small adjacent irregular solid masses. US-guided core biopsy yielded an invasive carcinoma of the tubular subtype that was estrogen receptor positive, progesterone receptor positive, and human epidermal growth factor receptor 2 negative. The results of the sentinel node biopsy were negative. Image courtesy of the Radiological Society of North America

News | Breast Imaging | March 11, 2020
March 11, 2020 — A new study published in the journal ...
SoftVue image stacks of sound speed, as shown for cases ranging across the four Breast Imaging Reporting and Data System (BI-RADS) breast density categories

Example: SoftVue image stacks of sound speed, as shown for cases ranging across the four Breast Imaging Reporting and Data System (BI-RADS) breast density categories ((a), fatty; (b), scattered; (c), heterogeneously dense; (d), extremely dense). Note the quantitative scale indicating that absolute measurements are obtained. Image courtesy of MDPI

News | Breast Imaging | March 10, 2020
March 10, 2020 — ...
The study concludes that a combination of Artificial Intelligence algorithms and the interpretations of radiologists could, in the U.S. alone, result in a half million women not having to undergo unnecessary diagnostic tests every year

Researchers who participated in the DM (digital mammography) DREAM Challenge.

News | Mammography | March 07, 2020
March 7, 2020 — The stu...
Christopher Comstock, M.D., ECOG-ACRIN Cancer Research Group study published in JAMA builds evidence for use of abbreviated MRI in women with dense breasts

Christopher Comstock, M.D., (Memorial Sloan Kettering Cancer Center) is the lead author of a paper in JAMA that reports that abbreviated breast MRI detected significantly more (almost 2 and a half times as many) breast cancers than digital breast tomosynthesis (3-D mammography) in average-risk women with dense breasts. Photo courtesy of Memorial Sloan Kettering Cancer Center

News | Breast Imaging | February 26, 2020
February 26, 2020 — According to a study
Women 75-plus May Not Benefit from Breast Cancer Screening
News | Mammography | February 25, 2020
February 25, 2020 — According to newly published research in an article titled...